ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,727.60
-1.08%
S&P ASX All Technology
3,063.80
-1.27%
Brent Oil
81.965
0.00%
US Dollar vs AUD
1.50943
0.00%
Bitcoin
68,722.50
0.28%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bioenvision (MM) (BIVN)

  7. Bioenvision (MM) (BIVN) News

BIVN

Bioenvision (BIVN)

Bioenvision (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIVN
DateTimeSourceHeadlineSymbolCompany
11/04/201722:30GlobeNewswire Inc.MonoSol Rx Appoints James S. Scibetta to Board of DirectorsNASDAQ:BIVNBioenvision (MM)
24/10/200707:40PR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer IndexNASDAQ:BIVNBioenvision (MM)
23/10/200706:50PR Newswire (US)Bioenvision Shareholders Approve Acquisition by Genzyme CorporationNASDAQ:BIVNBioenvision (MM)
11/10/200704:57PR Newswire (US)Delaware Court Approves Bioenvision, Genzyme Joint PetitionNASDAQ:BIVNBioenvision (MM)
06/10/200707:00Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
06/10/200707:00Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
05/10/200722:34Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
05/10/200722:34Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
05/10/200707:14Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
05/10/200707:14Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
01/10/200723:17Edgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
27/09/200722:45PR Newswire (US)Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding ShareNASDAQ:BIVNBioenvision (MM)
27/09/200722:31Edgar (US Regulatory)Bioenvision Inc (Other) (DFAN14A)NASDAQ:BIVNBioenvision (MM)
27/09/200722:30Edgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
21/09/200704:15Edgar (US Regulatory)Bioenvision Inc (Other) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
20/09/200707:11Edgar (US Regulatory)Bioenvision Inc (Other)NASDAQ:BIVNBioenvision (MM)
06/09/200723:49PR Newswire (US)Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues CompanyNASDAQ:BIVNBioenvision (MM)
16/08/200722:00Business WireBioenvision Provides Evoltra(R) (clofarabine) Regulatory UpdateNASDAQ:BIVNBioenvision (MM)
28/07/200708:24PR Newswire (US)Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
27/07/200706:30Business WireBioenvision, Inc. Says Securities Class Action Litigation Without MeritNASDAQ:BIVNBioenvision (MM)
16/07/200723:00Business WireDr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of DirectorsNASDAQ:BIVNBioenvision (MM)
11/07/200704:44PR Newswire (US)/C O R R E C T I O N -- Genzyme Corporation/NASDAQ:BIVN
10/07/200723:27PR Newswire (US)Genzyme Completes Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
03/07/200700:45PR Newswire (US)Genzyme Extends Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
28/06/200703:30PR Newswire (US)Genzyme Corporation Moves Closer to Acquiring Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
30/05/200700:09PR Newswire (US)Genzyme Corporation to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
08/05/200721:00Business WireBioenvision Reports Third Quarter 2007 Financial ResultsNASDAQ:BIVNBioenvision (MM)
07/05/200721:02Business WireBioenvision Receives $7.4 Million in Warrant Exercises by Perseus-Soros Biopharmaceutical Fund & SCO CapitalNASDAQ:BIVNBioenvision (MM)
03/05/200721:02Business WireBioenvision to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
01/05/200721:02Business WireBioenvision to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on Tuesday, May 8, 2007NASDAQ:BIVNBioenvision (MM)
 Showing the most relevant articles for your search:NASDAQ:BIVN

Your Recent History

LSE
MNE
Merrill Lynch New Energy Tech
TSXV
CSK
NASDAQ
CSPLF
Canada Southern Petroleum
LSE
0R9T
Equasens
USOTC
WNDHU
Windstream Holdings II (GM)
CSE
AYR.WT.U
Ayr Wellness
USOTC
BLFE
BioLife Sciences (CE)
NYSE
PIC.U
Pivotal Investment Corpo...
AMEX
BMV
EU
BPCRN
BPCE 1.739% until 28mar31
COIN
BAKEDGBP
LSE
BXTN
Brixton
GATE
PERAUSDT
Pera Finance
TSX
DSG
Descartes Systems
BIT
1WBD
Warner Bros Discovery
USOTC
UJOGF
Union Jack Oil (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved